维普中文期刊产品整合服务
60篇 您的检索式:作者名="Osafune"
    题名 作者 年代 出处 被引量
1Comparison of endoscopic stenting for malignant biliary obstruction: A single-center study显示文摘AIM: To evaluate the efficacy and safety of single-step endoscopic placement of self-expandable metallic stents(SEMS) for treatment of obstructive jaundice.METHODS: A retrospective study was performed among 90 patients who underwent transpapillary biliary metallic stent placement for malignant biliary obstruction(MBO) between April 2005 and October 2012. The diagnosis of primary disease and MBO was based on abdominal ultrasound, computed tomography, magnetic resonance imaging, endoscopic ultrasound, endoscopic retrograde cholangiopancreatography with brush cytology, biopsy, and/or a combination of these modalities. The type of SEMS(covered or non-covered, 8 mm or 10 mm in diameter) was determined by the endoscopist. Ninety patients were divided into two groups: group 1(49 patients) who underwent a singlestep SEMS placement and group 2(41 patients) who underwent a two-step SEMS placement. The technical success rate, complication rate, stent patency, and patient survival rate were compared between the groups. In addition, to identify the clinical prognostic factors associated with patient survival, the following variables were evaluated in Cox-regression analysis: gender, age, etiology of MBO(pancreatic cancer or nonpancreatic cancer), clinical stage(Ⅳb; with distant metastases or Ⅳa >; without distant metastases), chemotherapy(with or without), patency of the stent, and the use of single-step or two-step SEMS. RESULTS: Immediate technical success was achieved in 93.9%(46/49) in group 1 and in 95.1%(39/41) in group 2, with no significant difference(P = 1.0). Similarly, there was no difference in the complication rates between the groups(group 1, 4.1% and group 2, 4.9%; P = 0.62). Stent failure was observed in 10 cases in group 1(20.4%) and in 16 cases in group 2(39.0%). The patency of stent and patient survival revealed no difference between the two groups with Kaplan-Meier analysis, with a mean patency of 111 ± 17 d in group 1 and 137 ± 19 d in group 2(P = 0.91), and a mean survival of 178 ± 35 d in group 1 and 222 ± 23 d in group 2(P = 0.57). On the contrary, the number of days of hospitalization associated with first-time SEMS placement in group 1 was shorter when compared with that number in group 2(28 vs 39 d; P < 0.05). Multivariate analysis revealed that a clinical stage of Ⅳa >(P = 0.0055), chemotherapy(P = 0.0048), and no patency of the stent(P = 0.011) were independent prognostic factors associated with patient survival.CONCLUSION: Our results showed that single-step endoscopic metal stent placement was safe and effective for treating obstructive jaundice secondary to various inoperable malignancies.Ryuichi Yamamoto Masatomo Takahashi Yasuyo Osafune Katsuya Chinen Shingo Kato Sumiko Nagoshi Koji Yakabi 2015World Journal of Gastrointestinal Endoscopy2015,7,9:12
2Induction of pluripotent stem cells from primary human fibroblasts with only OCT4 and SOX2显示文摘Huangfu D Osafune K Maehr R 2008Nat Biotechnol2008,26,:1
3Ideal combination of dementia screening tests显示文摘Osafune M Deguchi K Abe K 2014Nihon Ronen Igakkai Zasshi2014,51,2:1
4Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2显示文摘Huangfu D Osafune K Maehr R 2008Nat Biotechnol2008,26,11:1
5Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2显示文摘HUANGFU D OSAFUNE K MAEHR R 2008Nature Biotechnology2008,26,:1
6Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 显示文摘Huangfu D Osafune K Maehr R 2008Nat Biotechno12008,26,:1
7Induction of pluripotent stem ceils from primary human fibroblasts with only Oct4 and Sox2显示文摘Huangfu D Osafune K Maehr R 2008Nature Biotech- nology2008,26,:1
8GaAs Ultra-High-Frequency Dividers with Advanced SAINT FET's显示文摘Osafune K Enoki T Yamasaki K and Ohwada K 1986IEEE Transactions on Microwave Theory and Techniques1986,34,12:1
9Induction of pluripo-tent stem cells from primary human fibroblasts with only Oct4and Sox2显示文摘Huangfu D Osafune K Maehr R et a1 2008Nat Biotechnol2008,26,11:1
10Electron microscopic studies onbactericidal effects of electrolyzed acidic water on bacteria derivedfrom kendo protective equipment显示文摘OSAFUNE T EHARA T ITO T 2006Environmental Health andPreventive Medicine2006,11,4:1
11Electron microscopic studies on bactericidal effects of electrolyzed acidic water on bacteria derived from kando protective equipment显示文摘OSAFUNE T EHARA T ITO T 0,,04:1
12Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 andSox2显示文摘D Huangfu K Osafune R Maehr W Guo 2008Nat Biotechnol2008,26,11:1
13Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes显示文摘Diabetes is among the top 10 causes of death in adults and caused approximately four million deaths worldwide in 2017.The incidence and prevalence of diabetes is predicted to increase.To alleviate this potentially severe situation,safer and more effective therapeutics are urgently required.Mice have long been the mainstay as preclinical models for basic research on diabetes,although they are not ideally suited for translating basic knowledge into clinical applications.To validate and optimize novel therapeutics for safe application in humans,an appropriate large animal model is needed.Large animals,especially pigs, are well suited for biomedical research and share many similarities with humans,including body size,anatomical features,physiology,and pathophysiology.Moreover,pigs already play an important role in translational studies,including clinical trials for xenotransplantation.Progress in genetic engineering over the past few decades has facilitated the development of transgenic animals,including porcine models of diabetes.This article discusses features that attest to the attractiveness of genetically modified porcine models of diabetes for testing novel treatment strategies using recent technical advances.Masaki Nagaya Koki Hasegawa Ayuko Uchikura Kazuaki Nakano Masahito Watanabe Kazuhiro Umeyama Hitomi Matsunari Kenji Osafune Eiji Kobayashi Hiromitsu Nakauchi Hiroshi Nagashima 2021World Journal of Diabetes2021,12,4:1
14Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2显示文摘Huangfu D Osafune K Maehr R 0,,11:1
15Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2显示文摘Huangfu D Osafune K Maehr R 2008Nat Biotech2008,26,11:1
16Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2显示文摘Huangfu D Osafune K Maehr R 2008Nat Biotechnol2008,26,11:1
17Characterization of an established cell line from human renal carcinoma显示文摘Matsuda M Osafune M Nakano E Kotake T Sononda T Watanabe S 1979Cancer Res1979,39,:1
18Induction of pluripotent stem ceils from primary human fibroblasts with only Oct4 and Sox2 显示文摘Huangfu Danwei Osafune K Maehr R 2008Nature Biotechnology2008,26,11:1
19Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2显示文摘Huangfu D Osafune K Maehr R 2008Nature Biotechnol2008,26,11:1
20Electron microscopic studies on bactericidal effects of electrolyzed acidic water on bacteria derived from Kendo protective equipment显示文摘Osafune T Ehara T Ito T 2006Environ Health Prevent Med2006,,11:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费